A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

November marks Diabetes Awareness Month, and Dr. Elizabeth Gersh is shedding light on the crucial differences between type 1 and type 2 diabetes. "Type one diabetes, usually you get it when you're ...

Researchers identify genetic markers that predict the rate of β-cell failure in type 1 diabetes, facilitating earlier, personalized care strategies Type 1 diabetes (T1D) is an autoimmune condition ...

In type 1 diabetes, the immune system has learned to attack islet cells in the pancreas and relentlessly destroy them. New ...

New guidance on the use of GLP-1-based drugs in people with type 1 diabetes (T1D), due to be published later this year, will address the safety and optimal use of these medications which are currently ...

A Garvan Institute of Medical Research-led clinical trial has found that using the type 2 diabetes (T2D) drug metformin reduces insulin needs in type 1 diabetes (T1D), a finding that could potentially ...

SHREVEPORT, La. -- A Shreveport mother has become just the second person in Northwest Louisiana to undergo a breakthrough treatment that can delay the onset of type 1 diabetes. For Nina Mooney, the ...